nextedge peptides
B2CAGreat
peptideone Score · 9.5/10
Composite of 1 independent source
Purity 9.5/10
Weighted blend of independent signals — Finnrick safety grade, VialAudit blind-buy audit, and Peptigrity HPLC purity. PeptideBenchmark and the Peptigrity trust score are excluded to avoid double-counting. Attributed to its sources — not our verdict.
Independent test grades (0)
Per Finnrick (independent testing). Attributed — Finnrick's grades, not ours.
| Peptide | Grade | Score |
|---|
Independent HPLC tests (8)
Real third-party HPLC results for this vendor, aggregated from Peptigrity and attributed to the lab that ran each test.
| Peptide | HPLC purity | Lab | Date |
|---|---|---|---|
| Tesamorelin | 99.03% | Janoshik Labs | 2026-04-15 |
| Tirzepatide | 99.85% | Janoshik Labs | 2026-04-15 |
| TB-500 | 99.03% | Janoshik Labs | 2026-04-15 |
| Retatrutide | 99.91% | Janoshik Labs | 2026-04-15 |
| BPC-157 | 99.67% | Janoshik Labs | 2026-04-15 |
| Semaglutide | 99.89% | Janoshik Labs | 2026-04-14 |
| Retatrutide | 99.89% | Janoshik Labs | 2026-04-14 |
| Retatrutide | 99.11% |